High-risk cutaneous squamous cell carcinoma of the head and neck: Results from 266 treated patients with metastatic lymph node disease

Cancer

Volumn 106, Issue 11, 2006, Pages 2389-2396

  Veness, Michael J ^a,b   Palme, Carsten E ^a   Morgan, Gary J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Cutaneous; Head and neck; Lymph nodes; Metastases; Squamous cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SIZE; FEMALE; HEAD AND NECK CARCINOMA; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; THICKNESS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS;

EID: 33646865910     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21898     Document Type: Article

References (40)

1. Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer. 1998;78:587-593.
2. de Vries E, van de Poll-Franse LV, Louwman WJ, de Gruijl FR, Coebergh JWW. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol. 2005;152:481-488.
3. Nolan RC, Chan MTL, Heenan PJ. A clinicopathologic review of lethal nonmelanoma skin cancers in Western Australia. J Am Acad Dermatol. 2005;52:101-108.
4. Veness MJ, Morgan GJ, Palme CE, Gebski V. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope. 2005;115:870-875.
5. Czarnecki D, Staples M, Mar A, Giles G, Meehan C. Métastases from squamous cell carcinoma of the skin in Southern Australia. Dermatology. 1994;189:52-54.
6. Nixon RL, Dorevitch AP, Marks R. Squamous cell carcinoma of the skin. Accuracy of clinical diagnosis and outcome of follow-up in Australia. Med J Aust. 1986;144:235-239.
7. Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg. 2002;28:268-273.
8. Rowe DE, Carroll RJ, Day CD. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear and lip. J Am Acad Dermatol. 1992;26:976-990.
9. Veness MI, Palme CE, Smith M, Cakir B, Morgan GJ, Kalnins I. Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy. Laryngoscope. 2003;113:1827-1833.
10. Sobin LH, Wittekind C, editors. TNM Classification of Malignant Tumours, 6th ed. New York: John Wiley & Sons; 2002.
11. Clayman GL, Lee JJ, Holsinger C, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol. 2005;23:759-765.
12. kip1 protein expression. Oral Oncol. 2004;40:92-98.
13. Brueuninger H, Black B, Rassner G. Brief scientific statement: microstaging of squamous cell carcinomas. Am J Clin Pathol. 1990;94:624-627.
14. Kraus DH, Carew JF, Harrison LB. Regional lymph node metastasis from cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1998;124:582-587.
15. Moore BA, Weber RS, Prieto V, et al. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope. 2005;115;1561-1567.
16. Dinehart SM, Pollack SV. Metastases from squamous cell carcinoma of the skin and lip. J Am Acad Dermatol. 1989;21:241-248.
17. Stein AL, Tahan SR. Histologic correlates of metastasis in primary invasive squamous cell carcinoma of the lip. J Cutan Pathol. 1994;21:16-21.
18. Onerci M, Yilmaz T, Gedikoglu G. Tumor thickness as a predictor of cervical lymph node metastasis in squamous cell carcinoma of the lower lip. Otolaryngol Head Neck Surg. 2000;122:139-142.
19. Frierson HF, Cooper PH. Prognostic factors in squamous cell carcinoma of the lower lip. Hum Pathol. 1986;17:346-354.
20. Breuninger H, Schaumburg-Lever G, Holzschuh J, Horny HP. Desmoplastic squamous cell carcinoma of skin and vermilion surface. Cancer. 1997;79:915-919.
21. Dinehart SM, Nelson-Adesokan P, Cockerell C, Russell S, Brown R. Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis. Cancer. 1997;79:920-923.
22. Grover R, Douglas RG, Shaw HFS. Carcinoma of the lip in Auckland, New Zealand, 1969-1987. Head Neck. 1989;11:264-268.
23. Petter G, Haustein UF. Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg. 2000;26:521-530.
24. Fowler BZ, Crocker IR, Johnstone PAS. Perineural spread of cutaneous malignancy: a review of the literature and five patients treated with stereotactic radiotherapy. Cancer. 2005;103:2043-2053.
25. Goepfert H, Dichtel WJ, Medina JE, Lindberg RD, Luna MD. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg. 1984;148:542-547.
26. Garcia-Serra A, Hinerman RW, Mendenhall WM, et al. Carcinoma of the skin with perineural invasion. Head Neck. 2003;25:1027-1033.
27. Afzelius LE, Gunnarsson M, Nordgren H. Guidelines for prophylactic radical lymph node dissection in cases of carcinoma of the external ear. Head Neck Surg. 1990;2:361-365.
28. Lee D, Nash M, Har-El G. Regional spread of auricular and preauricular cutaneous malignancies. Laryngoscope. 1996;106:998-1001.
29. Tavin E, Persky M. Metastatic cutaneous squamous cell carcinoma of the head and neck region. Layngoscope. 1996;106:156-158.
30. Yooh M, Chougule P, Dufresne R, Wanebo HJ. Localized carcinoma of the external ear is an unrecognized aggressive disease with a high propensity for local regional recurrence. Am J Surg. 1992;164:574-577.
31. Lai SY, Weinstein GS, Chalian AA, Rosenthal DI, Weber RS. Parotidectomy in the treatment of aggressive cutaneous malignancies. Arch Otolaryngol Head Neck Surg. 2002;128:521-526.
32. O'Brien CJ. The parotid gland as a metastatic basin for cutaneous cancer. Arch Otolaryngol Head Neck Surg. 2005;131:551-555.
33. Maubec E, Duvillard P, Velasco V, Crickx B, Avril MF. Immunohistochemical analysis of EGFR and HER-2 patients with metastatic squamous cell carcinoma of the skin. Anticancer Res. 2005:1205-1210.
34. Shell AG, Disney AP, Mathew TH, Amiss N. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc. 1993;25:1383-1384.
35. Veness MJ, Quinn DI, Ong CS, et al. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer. 1999;85:1758-1764.
36. Martinez JC, Clark CO, Stasko T, et al. Defining the clinical course of metastatic skin cancer in organ transplant recipients. Arch Dermatol. 2003;139:301-306.
37. Kowalski LP. Results of salvage treatment of the neck in patients with oral cancer. Arch Otolaryngol Head Neck Surg. 2002;128:58-62.
38. Reschly MJ, Messina JL, Zaulyanov LL, Cruse W, Fenske NA. Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma. Dermatol Surg. 2003;29:135-140.
39. Wagner JD, Evdokimow DZ, Weisberger E, et al. Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol. 2004;140:75-79.
40. Kwan W, Wilson D, Moravan M. Radiotherapy for locally advanced basal cell and squamous cell carcinoma of the skin. Int J Radiat Oncol Biol Phys. 2004;60:406-411.